Table 1.
Characteristic or Measure | n | Mean ± SD (Median, Range) or n (%) |
---|---|---|
Age | 117 | 39.0 ± 12.9 (35, 21–72) |
21–29 | 33 (28.2) | |
30–39 | 37 (31.6) | |
40–49 | 23 (19.7) | |
50–59 | 11 (9.4) | |
> 60 | 13 (11.1) | |
Race | 117 | |
Asian | 4 (3.4) | |
African American/black | 6 (5.1) | |
Other | 4 (3.4) | |
White | 103 (88.1) | |
BMI | 117 | 27.0 ± 5.7 (26.5, 18.2–51.6) |
<19.0 | 1 (0.9) | |
19.0–24.9 | 47 (40.2) | |
25.0–29.9 | 42 (35.9) | |
30.0–39.9 | 24 (20.5) | |
40+ | 3 (2.6) | |
Comorbidities | 117 | |
None | 102 (87.2) | |
One | 13 (11.1) | |
Two | 1 (0.9) | |
Three | 1 (0.9) | |
Smoking status | 117 | |
Current smoker | 2 (1.7) | |
Former smoker | 21 (18.0) | |
Nonsmoker | 94 (80.3) | |
Pack-years | 117 | 1.2 ± 3.6 (0, 0–23.5) |
DNAm | 117 | 27.1 ± 14.1 (22.9, 9.1–65.2) |
p16INK4a | 114 | 3.0 ± 1.0 (2.9, 0.4–6.6) |
% CD3+ | 116 | 96.0 ± 4.9 (97.0, 60.9–98.7) |
CMV seropositivity | 117 | |
Yes | 45 (38.5) | |
No | 72 (61.5) | |
CMV antibody titer | 45 | 2.8 ± 0.4 (2.9, 2.0–3.5) |